Is hemolysis a novel therapeutic target in COVID-19?
Daiki OusakaMasahiro Nishibori
FRONTIERS IN IMMUNOLOGY
FRONTIERS MEDIA SA
13
10.3389/fimmu.2022.956671
https://doi.org/10.3389/fimmu.2022.956671https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000849150400001&DestApp=WOS_CPL